Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

35.61
+1.313.82%
Post-market: 36.030.4200+1.18%19:59 EST
Volume:17.34M
Turnover:633.05M
Market Cap:13.74B
PE:-3.84
High:37.91
Open:34.47
Low:33.93
Close:34.30
Loading ...
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Proposed Sale Of Securities

Form 144 | Moderna, Inc.'s Officer Shannon Klinger proposes to sell 529 Shares, with a total value of approximately $23,637.31.
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 29, 2024

Proposed Sale Of Securities

Form 144 | Moderna's Officer Stephen Hoge proposes to sell 291 Shares, with a total value of approximately $12,451.
Nov 29, 2024

Proposed Sale Of Securities

Form 144 | Moderna's Officer Klinger Shannon proposes to sell 1418 shares, with a total value of approximately $60674.95.
Nov 29, 2024

Proposed Sale Of Securities

Form 144 | Moderna's Officer James Mock proposes to sell 1420 shares, with a total value of approximately $60,760.52.
Nov 12, 2024

Proposed Sale Of Securities

Form 144 | Moderna's Officer Stephen Hoge proposes to sell 277 Shares, with a total value of approximately $12,771.
Nov 08, 2024

Quarterly Report

Moderna's Q3 Net Loss Narrows to $2.4 Billion as COVID-19 Sales Decline and RSV Vaccine Launches
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report